These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10628379)

  • 1. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients.
    Sandler B; Smirnoff P; Shani A; Idelevich E; Kaganski N; Pfefferman R; Davidovich B; Zusman I
    Anticancer Res; 1999; 19(5B):4229-33. PubMed ID: 10628379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detection.
    Zusman I; Sandler B; Gurevich P; Zusman R; Smirnoff P; Tendler Y; Bass D; Shani A; Idelevich E; Pfefferman R; Davidovich B; Huszar M; Glick J
    Hum Antibodies Hybridomas; 1996; 7(3):123-8. PubMed ID: 9057060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
    Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum anti-p53 antibodies and CEA in monitoring of recurrences of colorectal cancer].
    Bielicki D; Sulzyc-Bielicka V; Domagała W
    Ann Acad Med Stetin; 2008; 54(3):99-104. PubMed ID: 19839520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
    Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
    Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
    Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal cancer].
    Takahashi Y
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Tsahalis T; Altsitsiadis E; Betsis D
    J Surg Oncol; 2006 Jul; 94(1):3-8. PubMed ID: 16788936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer].
    Reginster JY; Desaive C; Collette J; Zangerle PF; Denis D; Franchimont P
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):203-6. PubMed ID: 6529177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer.
    Bhatnagar J; Tewari HB; Bhatnagar M; Austin GE
    Anticancer Res; 1999; 19(3B):2181-7. PubMed ID: 10472328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.